Puissance Capital Management

Latest statistics and disclosures from Puissance Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Puissance Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Puissance Capital Management

Puissance Capital Management holds 5 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bellerophon Therapeutics Com New 67.7 $12M 1.2M 10.18
 View chart
Ekso Bionics Hldgs 21.2 $3.7M 774k 4.75
 View chart
Scynexis Com New (SCYX) 7.9 $1.4M NEW 311k 4.41
 View chart
Kadmon Hldgs 2.3 $393k NEW 100k 3.92
 View chart
Corvus Pharmaceuticals (CRVS) 0.9 $152k 38k 4.00
 View chart

Past Filings by Puissance Capital Management

SEC 13F filings are viewable for Puissance Capital Management going back to 2017